VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
INDV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
INDVIndivior Pharmaceuticals Inc
$36.28$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksINDVQuarterly Cash Flow

Indivior Pharmaceuticals Inc (INDV) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Indivior Pharmaceuticals Inc (INDV) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

INDV Cash Flow Statement

Quarterly statement

INDV Cash Flow Statement

Indivior Pharmaceuticals Inc (INDV) cash flow statement — 10-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations97M229M-9M-221M-39M158M75M-5M2M88M-37M-279.72M21.17M-19.83M-36M-16.87M59.51M28.55M-75M160.29M
Operating CF Margin %27.25%66.76%-2.84%-61.73%-12.42%52.32%28.2%-1.67%0.65%29.43%-13.03%-95.47%7.81%-7.19%-14.23%-6.97%25.65%12.92%-36.23%71.88%
Operating CF Growth %348.72%44.94%-112%-4320%-2050%79.55%302.7%98.21%-90.55%543.7%-2.78%-1558.38%-64.43%-169.46%52%-110.52%----
Net Income137M122M89M102M43M18M47M66M22M-97M61M54M-135M39M57M-183M41M48M54M35M
Depreciation & Amortization1M3M4M5M5M5M5M5M8M6M5M9M7M6M6M4M6M6M5M4M
Stock-Based Compensation8M11M9M5M7M8M6M6M6M6M6M0005M0003M0
Deferred Taxes-17M25M27M-38M-15M000000000000000
Other Non-Cash Items4M4M25M4M18M6M-1M42M4M-17M4M23.88M-62.25M22.39M-42M-70.69M-3.37M-10.78M-22M-18.3M
Working Capital Changes-36M64M-163M-299M-97M121M18M-124M-38M190M-113M-366.59M211.42M-87.23M-62M232.82M15.88M-14.67M-115M139.59M
Change in Receivables-2M20M-20M6M-18M4M11M-4M9M-10M5M-6.43M-18.39M-15.12M7M-21.86M-1.04M-3.1M6M-27.49M
Change in Inventory1M1M-1M2M-6M17M5M-9M-6M-8M-21M5.55M-15.34M-6.17M-5M-3.29M-10.84M-11.68M2M2.05M
Change in Payables0000000000022M31.87M30.91M0-23.36M-41.89M46.94M0167.03M
Cash from Investing-14M-8M-19M-24M-20M-17M-5M10M35M1M25M8.23M-1.47M22.44M-127M-6.22M-49.37M-7.76M-149M-1.74M
Capital Expenditures-14M-7M-20M-24M-20M-17M-5M-16M-7M-4M-2M-17.21M-28.58M-1.11M-1M-1.98M-1.8M-1.94M0-1.38M
CapEx % of Revenue3.93%2.04%6.31%6.7%6.37%5.63%1.88%5.35%2.28%1.34%0.7%5.87%10.55%0.4%0.4%0.82%0.77%0.88%-0.62%
Acquisitions00000000000-2.32M-544.94K-1.88M-124M00000
Investments--------------------
Other Investing0-1M0001M-1M01M-1M0000-5M19.51K-34.97K-32.32K1M-361.63K
Cash from Financing-254.11K-173M7M-5M-3M-5M-17M27M-51M-35M-56M-20.42M-1.13M-2.36M-22M-28.07M-34.25M-30.9M-2M-66.17M
Debt Issued (Net)231.15K0156M-5M-4M-4M-4M101M-1M0-1M12.23M-1.07M-166.62K-11M1.87M-1.87M32.32K-1M-253.14K
Equity Issued (Net)-462.3K-176M-147M-2M2M-1M-13M-50M-49M-36M-35M-21.81M2M-136.32K-9M-24.1M-31.63M-29.06M1M-64.06M
Dividends Paid00000000000000000000
Share Repurchases-462.3K-176M-126M000-11M-51M-51M-35M-36M-21.72M-48.34K-166.62K-11M-24.14M-33.5M-28.06M0-65.04M
Other Financing-22.96K3M-2M2M-1M00-24M-1M1M-20M-10.85M-2.06M-2.06M-2M-5.83M-757.88K-1.87M-2M-1.85M
Net Change in Cash83M48M-20M-250M-64M137M53M31M-14M54M-68M-294M18M4M-186M-47M-36M-17M-228M97M
Free Cash Flow83M222M-29M-245M-59M140M70M-21M-5M84M-40M-283.62M19.12M-20.86M-42M-17.9M57.71M26.62M-75M158.37M
FCF Margin %23.31%64.72%-9.15%-68.44%-18.79%46.36%26.32%-7.02%-1.63%28.09%-14.08%-96.8%7.06%-7.56%-16.6%-7.4%24.88%12.04%-36.23%71.02%
FCF Growth %240.68%58.57%-141.43%-1066.67%-1080%66.67%275%92.6%-126.15%502.62%4.76%-1484.73%-66.87%-178.39%44%-111.3%----
FCF per Share0.681.72-0.22-1.96-0.461.130.57-0.16-0.040.62-0.29-2.000.14-0.15-0.30-0.130.390.19-0.501.13
FCF Conversion (FCF/Net Income)0.71x1.88x-0.10x-2.17x-0.93x8.78x1.60x-0.08x0.50x-0.91x-0.61x-5.18x-0.16x-0.51x-0.82x0.09x1.45x0.59x-1.83x4.45x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000